Table 3. | Stage I/II | Stage III | Stage IV | Stage V | p |
---|---|---|---|---|---|
N=20 | N=20 | N=20 | N=20 | ||
E/A | 0.8 (0.8-1.1) | 0.8 (0.7-0.95) | 0.9 (0.8-1.2) | 0.9 (0.8-1.3) | NS |
E/E’ | 7.4±2.0 | 8.1±3.9 | 7.1±3.5 | 13.6±4.41,3,6 | P=0.001 |
Diastolic dysfunction [%] | 81.8 | 93.3 | 100.0 | 94.7 | NS |
Contractility disorders [%] | 33.3 | 42.9 | 36.4 | 78.91,5 | P=0.040 |
Mitral valve fibrosis [%] | 81.8 | 80.0 | 70.6 | 90.5 | NS |
Aortic valve fibrosis [%] | 9.1 | 20.0 | 23.5 | 4.8 | NS |
Mitral valve calcifications [%] | 0 | 0 | 17.6 | 28.61 | P=0.044 |
Aortic valve calcifications [%] | 0 | 13.3 | 23.5 | 61.92,5 | P=0.0008 |
IM [%] | 54.5 | 50.0 | 58.8 | 81.0 | NS |
IA [%] | 10.0 | 12.5 | 0 | 4.8 | NS |
IT [%] | 27.3 | 25.0 | 37.5 | 71.41 | P=0.016 |